Return to Epstein's Page

<--Return to Cancer Prevention Coalition Page

Environmental Health Network News Report

Perfume: Cupid's Arrow or Poison Dart , of PR Newswire


Joint Release Issued by the Cancer Prevention Coalition and the Environmental Health Network

CHICAGO, Feb. 7 , 2000/PRNewswire/ -- The following was released today by Samuel S. Epstein, M.D., Professor of Environmental Medicine, University of Illinois School of Public Health, Chicago, and Chairman of the Cancer Prevention Coalition, and Amy Marsh, President of the Environmental Health Network, Larkspur, California:

Perfume: Cupid's Arrow or Poison Dart

Lovers looking for the perfect Valentine's gift should think twice before giving a bottle of toxic chemicals to their sweethearts. Recent analysis of Calvin Klein's "Eternity Eau de Parfum" (Eternity) by an industry laboratory specializing in fragrance chemistry revealed 41 ingredients. These include some known to be toxic to the skin, respiratory tract, nervous, and reproductive systems, and others known to be carcinogens; no toxicity data are available on several ingredients, while data on most are inadequate. Additionally, some ingredients are volatile and a source of indoor air pollution. Since 1995, several consumers have complained to the Food and Drug Administration (FDA) of neurological and respiratory problems due to Eternity.

The analysis was recently commissioned by the Environmental Health Network (EHN) as many members had complained of asthma, migraine, sensitization, or multiple chemical sensitivity when exposed to Eternity. Based on this analysis, EHN filed a Citizen Petition with the FDA on May 11, 1999, which was subsequently endorsed by the Cancer Prevention Coalition. The petition requests that the FDA take administrative action and declare Eternity "misbranded" or "adulterated" since it does not carry a warning label as required by the terms of the Food, Drug, and Cosmetic Act and the Fair Packaging and Labeling Act. Grounds for requesting the warning label include FDA regulation 21CFR Sec. 740/10: "Each ingredient used in a cosmetic product and each finished cosmetic product shall be adequately substantiated for safety prior to marketing. Any such ingredient or product whose safety is not adequately substantiated prior to marketing is misbranded unless it contains the following conspicuous statement on the principal display panel: Warning: the safety of this product has not been determined."

Since May, over 700 consumers with health problems from exposure to various mainstream fragrances have written to the FDA supporting EHN's petition. The FDA responded on November 30 to the effect that they had been unable to reach a decision on the grounds of "other priorities and the limited availability of resources." The petition is thus still open for further public complaints and endorsements.

A wide range of mainstream fragrances and perfumes, predominantly based on synthetic ingredients, are used in numerous cosmetics and toiletries, and also soaps and other household products. Currently, the fragrance industry is virtually unregulated. Its recklessness is abetted and compounded by FDA's complicity. The FDA has refused to require the industry to disclose ingredients due to trade secrecy considerations, and still takes the position that "consumers are not adversely affected -- and should not be deprived of the enjoyment" of these products. The Cancer Prevention Coalition and EHN take the unequivocal position that the FDA should implement its own regulations and act belatedly to protect consumer health and safety.

Valentine sweethearts should switch to organically grown (pesticide-free) roses or other flowers as safe alternatives to mainstream perfumes.


or Barbara Wilkie of the Environmental Health Network
P.O. Box 1155, Larkspur, CA 94977; phone: 415.541.5075 -- message system; or e-mail:  Website:

or Shelley Kramer, Public Health and Cancer Prevention Educator and Director of the  Los Angeles Chapter of the  Cancer Prevention Coalition  Website:

SOURCE Cancer Prevention Coalition and Environmental Health Network

02/07/2000 CB-JK -- CGM063 -- 4301 02/07/2000 16:01 EST

PR Newswire:

# # # #

Visit to EHN Petitions the FDA

To view a sample letter, visit:

Fragrance information can be found on the following website:
Fragranced Products Information Network
By Betty Bridges, RN

Reach us by e-mail:

Amy Marsh, President EHN

Betty Bridges, RN; EHN Advisory Board and FPIN

Barb Wilkie, board member, EHN


Please write to the FDA in support of this petition.
Reference Docket Number 99P-1340/CP 1 and e-mail, fax or mail to:

Email Address --

FAX Number -- 301.827.6870

Letters may be mailed to:

Dockets Management Branch
The Food and Drug Administration
Department of Health and Human Services, Rm. 1-23
12420 Parklawn Dr.
Rockville, MD 20857

top of page

Copyright Telephone: 310-457-5176

For General Information:

Webmaster for Shelley R. Kramer